CL2007002362A1 - Forma de cristal de la epotilona b; composicion farmaceutica que la comprende; y uso para el tratamiento de una enfermedad proliferativa, tal como un tumor. - Google Patents
Forma de cristal de la epotilona b; composicion farmaceutica que la comprende; y uso para el tratamiento de una enfermedad proliferativa, tal como un tumor.Info
- Publication number
- CL2007002362A1 CL2007002362A1 CL200702362A CL2007002362A CL2007002362A1 CL 2007002362 A1 CL2007002362 A1 CL 2007002362A1 CL 200702362 A CL200702362 A CL 200702362A CL 2007002362 A CL2007002362 A CL 2007002362A CL 2007002362 A1 CL2007002362 A1 CL 2007002362A1
- Authority
- CL
- Chile
- Prior art keywords
- epotilone
- understands
- tumor
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06119043 | 2006-08-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2007002362A1 true CL2007002362A1 (es) | 2008-08-08 |
Family
ID=37685905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200702362A CL2007002362A1 (es) | 2006-08-16 | 2007-08-14 | Forma de cristal de la epotilona b; composicion farmaceutica que la comprende; y uso para el tratamiento de una enfermedad proliferativa, tal como un tumor. |
Country Status (22)
Country | Link |
---|---|
US (1) | US8178566B2 (es) |
EP (1) | EP2064216A2 (es) |
JP (1) | JP2010500387A (es) |
KR (1) | KR20090038902A (es) |
CN (1) | CN101506217B (es) |
AR (1) | AR062375A1 (es) |
AU (1) | AU2007286454A1 (es) |
BR (1) | BRPI0715963A2 (es) |
CA (1) | CA2658475A1 (es) |
CL (1) | CL2007002362A1 (es) |
IL (1) | IL196558A0 (es) |
MA (1) | MA30656B1 (es) |
MX (1) | MX2009001635A (es) |
MY (1) | MY148355A (es) |
NO (1) | NO20091081L (es) |
NZ (1) | NZ574194A (es) |
PE (1) | PE20081317A1 (es) |
RU (1) | RU2009109352A (es) |
TN (1) | TN2009000044A1 (es) |
TW (1) | TW200815455A (es) |
WO (1) | WO2008019820A2 (es) |
ZA (1) | ZA200900227B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5881254B2 (ja) | 2010-05-18 | 2016-03-09 | セルリアン・ファーマ・インコーポレイテッド | 自己免疫疾患およびその他の疾患の治療のための組成物および方法 |
CN103910742B (zh) * | 2013-01-07 | 2016-07-13 | 浙江海正药业股份有限公司 | 一种制备埃博霉素b无定形粉末的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID26549A (id) | 1998-02-05 | 2001-01-18 | Novartis Ag | Komposisi-komposisi epotilon |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
UA75365C2 (en) | 2000-08-16 | 2006-04-17 | Bristol Myers Squibb Co | Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon |
GB0029895D0 (en) | 2000-12-07 | 2001-01-24 | Novartis Ag | Organic compounds |
KR20050053681A (ko) * | 2002-09-23 | 2005-06-08 | 브리스톨-마이어스 스큅 컴퍼니 | 에포틸론 b의 제조, 분리 및 정제 방법, 및 에포틸론 b의x-선 결정 구조 |
-
2007
- 2007-08-14 CA CA002658475A patent/CA2658475A1/en not_active Abandoned
- 2007-08-14 MY MYPI20090415A patent/MY148355A/en unknown
- 2007-08-14 MX MX2009001635A patent/MX2009001635A/es not_active Application Discontinuation
- 2007-08-14 EP EP07801648A patent/EP2064216A2/en not_active Withdrawn
- 2007-08-14 JP JP2009524113A patent/JP2010500387A/ja active Pending
- 2007-08-14 CN CN2007800304132A patent/CN101506217B/zh not_active Expired - Fee Related
- 2007-08-14 US US12/376,973 patent/US8178566B2/en not_active Expired - Fee Related
- 2007-08-14 WO PCT/EP2007/007173 patent/WO2008019820A2/en active Application Filing
- 2007-08-14 CL CL200702362A patent/CL2007002362A1/es unknown
- 2007-08-14 AR ARP070103603A patent/AR062375A1/es not_active Application Discontinuation
- 2007-08-14 BR BRPI0715963-3A patent/BRPI0715963A2/pt not_active IP Right Cessation
- 2007-08-14 NZ NZ574194A patent/NZ574194A/en not_active IP Right Cessation
- 2007-08-14 RU RU2009109352/04A patent/RU2009109352A/ru not_active Application Discontinuation
- 2007-08-14 PE PE2007001090A patent/PE20081317A1/es not_active Application Discontinuation
- 2007-08-14 AU AU2007286454A patent/AU2007286454A1/en not_active Abandoned
- 2007-08-14 KR KR1020097002958A patent/KR20090038902A/ko not_active Application Discontinuation
- 2007-08-15 TW TW096130206A patent/TW200815455A/zh unknown
-
2009
- 2009-01-12 ZA ZA2009/00227A patent/ZA200900227B/en unknown
- 2009-01-15 IL IL196558A patent/IL196558A0/en unknown
- 2009-02-13 TN TN2009000044A patent/TN2009000044A1/fr unknown
- 2009-02-20 MA MA31654A patent/MA30656B1/fr unknown
- 2009-03-11 NO NO20091081A patent/NO20091081L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ574194A (en) | 2011-12-22 |
AU2007286454A1 (en) | 2008-02-21 |
MA30656B1 (fr) | 2009-08-03 |
CN101506217B (zh) | 2012-09-05 |
TN2009000044A1 (en) | 2010-08-19 |
US20100160393A1 (en) | 2010-06-24 |
CA2658475A1 (en) | 2008-02-21 |
KR20090038902A (ko) | 2009-04-21 |
NO20091081L (no) | 2009-03-16 |
BRPI0715963A2 (pt) | 2013-08-06 |
WO2008019820A3 (en) | 2008-04-17 |
IL196558A0 (en) | 2009-11-18 |
MX2009001635A (es) | 2009-02-23 |
PE20081317A1 (es) | 2008-10-28 |
WO2008019820A2 (en) | 2008-02-21 |
AR062375A1 (es) | 2008-11-05 |
ZA200900227B (en) | 2009-12-30 |
MY148355A (en) | 2013-03-29 |
RU2009109352A (ru) | 2010-09-27 |
CN101506217A (zh) | 2009-08-12 |
JP2010500387A (ja) | 2010-01-07 |
US8178566B2 (en) | 2012-05-15 |
EP2064216A2 (en) | 2009-06-03 |
TW200815455A (en) | 2008-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007002234A1 (es) | Compuestos derivados de heterociclos de nitrogeno; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades proliferativas. | |
CL2007003226A1 (es) | Compuestos derivados de piridinona; composicion farmaceutica; y uso para tratar el cancer. | |
CL2007003138A1 (es) | Compuestos derivados de anilinopiperazina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. | |
BRPI0912539A2 (pt) | composto, composição farmacêutica , método para tratar uma doença, e, uso do composto. | |
CL2016000117A1 (es) | Autotaxina inhibidores comprende un anillo heteroaromático-bencilamina ciclo basico | |
CL2008000691A1 (es) | Compuestos derivados de dihidro y tetrahidro oxazolopirimidinonas sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la esquizofrenia, epilepsia, entre otras enfermedades. | |
BRPI0922475A2 (pt) | composto, composição farmacêutica , método para tratar câncer, e, uso de um composto. | |
CL2012003281A1 (es) | Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica. | |
BRPI0806531A2 (pt) | Composto, composição farmacêutica, agente terapêutico, e, uso do composto. | |
BRPI0813237A2 (pt) | Composto, método para preparar o composto, composição, medicamento, e, uso do composto. | |
CR11019A (es) | 3-imidazolil-indoles para el tratamiento de enfermedades proliferativas | |
CL2011003350A1 (es) | Compuestos derivados de heterociclo nitrogenados, moduladores pkm2; composicion farmaceutica que los comprende; y su uso en el tratamiento del cancer. | |
CL2007003520A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer. | |
CL2008000403A1 (es) | Compuestos derivados de pentafluorotiobenzamido-acetonitrilo; composicion farmaceutica; y uso para tratar una infestacion por parasitos. | |
CL2007003100A1 (es) | Compuestos derivados de pirimidina, inhibidores de cisteina proteasa; procesos de preparacion; sales de los compuestos; composicion farmaceutica; y uso para el tratamiento de la malaria. | |
CL2007002121A1 (es) | Compuestos derivados de pirazoles, activadores de glucoquinasa; proceso de preparacion de dichos compuestos; composicion farmaceutica que comprende dichos compuestos; y uso para el tratamiento de enfermedades y/o trastornos metabolicos, tal como diab | |
BRPI0917705A2 (pt) | composto, pró-droga, composição farmacêutica, método para tratar ou prevenir uma doença ou condição, e, uso do composto | |
CL2007001630A1 (es) | Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c. | |
CL2007003389A1 (es) | Formas cristalinas de sales de acido zoledronico; composicion farmaceutica; y uso en el tratamiento del cancer. | |
CL2008002295A1 (es) | Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c. | |
BRPI0906576A2 (pt) | Composição farmacêutica, kit, uso de um composto, e, agente terapêutico para câncer | |
CL2007002920A1 (es) | Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos. | |
BRPI0922233A2 (pt) | compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas. | |
BRPI0914410A2 (pt) | composição de polidesoxirribonucleotídeo injetável para o tratamento de doenças osteoarticulares. | |
BR112012003280A2 (pt) | composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto. |